BIVDA Reports & Position Papers

BIVDA's response to relevant legislation issues and key reports from the sector.

Industry Clarification Statement DCB0129 - September 2023

This statement is to clarify that DCB0129 (often requested as part of DTAC) is not required for analysers and analytical platforms that are standalone, not embedded and are regulated in their own right as medical devices.
BIVDA UKCA Sub-group policy paper: Labelling
02/06/2023
READ MORE
In Vitro Diagnostic Test Procurement during the COVID-19 Pandemic
15/05/2023
READ MORE
Leveraging partnerships to realise the UK’s potential in genomics
15/05/2023
READ MORE
Testing Times
22/09/2022
READ MORE
Inflationary Price Pressures Industry Position Statement
08/07/2022
READ MORE
Near Patient Testing - The Value Story
09/04/2019
READ MORE
Brexit: The Perspective of the in vitro diagnostics (IVD) industry - August 2018
16/08/2018
READ MORE
Three simple tests could save the NHS at least £6.9 billion
19/06/2018
READ MORE